1 | 1957235-98-1 | Thalidomide-O-C6-NH2 | Thalidomide-O-C6-NH2 | C19H23N3O5
| 定制产品-周期2~3周,先制备后付款 | 定制产品-周期2~3周,先制备后付款 |
2 | 873302-31-9 | Varenicline N-Glucoside | Varenicline N-Glucoside | C19H23N3O5
| | |
3 | 52555-26-7 | N-(4-nitro-1-cyclohexyl-2-oxo-3-pyrrolin-3-yl)phenylalanine | N-(4-nitro-1-cyclohexyl-2-oxo-3-pyrrolin-3-yl)phenylalanine | C19H23N3O5
| | |
4 | 331441-44-2 | N-[2-(3,4-dimethoxyphenyl)ethyl]-3-(2-furoylhydrazono)butanamide | N-[2-(3,4-dimethoxyphenyl)ethyl]-3-(2-furoylhydrazono)butanamide | C19H23N3O5
| | |
5 | 2743431-94-7 | 5-((6-aminohexyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | 5-((6-aminohexyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | C19H23N3O5
| | |
6 | 2763751-66-0 | 伊托必利杂质03 | Benzamide, 3,4-dimethoxy-N-[[4-[2-(methylnitrosoamino)ethoxy]phenyl]methyl]- | C19H23N3O5
| | |
7 | 1010925-33-3 | tert-butyl 4-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]piperazine-1-carboxylate | tert-butyl 4-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]piperazine-1-carboxylate | C19H23N3O5
| | |
8 | 1212408-31-5 | 2-[(2-{4-[(cyclopropylcarbonyl)amino]benzoyl}hydrazino)carbonyl]cyclohexanecarboxylic acid | 2-[(2-{4-[(cyclopropylcarbonyl)amino]benzoyl}hydrazino)carbonyl]cyclohexanecarboxylic acid | C19H23N3O5
| | |
9 | 339335-79-4 | ethyl 4-{[2-(2,5-dimethoxybenzylidene)hydrazino]carbonyl}-3,5-dimethyl-1H-pyrrole-2-carboxylate | ethyl 4-{[2-(2,5-dimethoxybenzylidene)hydrazino]carbonyl}-3,5-dimethyl-1H-pyrrole-2-carboxylate | C19H23N3O5
| | |
10 | | (1S,2R)-2-[(2-(4-[(CYCLOPROPYLCARBONYL)AMINO]BENZOYL)HYDRAZINO)CARBONYL]CYCLOHEXANECARBOXYLIC ACID | (1S,2R)-2-[(2-(4-[(CYCLOPROPYLCARBONYL)AMINO]BENZOYL)HYDRAZINO)CARBONYL]CYCLOHEXANECARBOXYLIC ACID | C19H23N3O5
| | |
11 | 2229976-11-6 | 叔-丁基 2-{[2-(2,6-二氧亚基哌啶-3-基)-1-氧亚基-2,3-二氢-1H-异吲哚-4-基]氨基}醋酸盐 | Glycine, N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-, 1,1-dimethylethyl ester | C19H23N3O5
| | |
12 | | 4-([4-(2,6-DIMETHYLMORPHOLIN-4-YL)-6-HYDROXY-1-METHYL-2-OXO-1,2-DIHYDROPYRIMIDIN-5-YL]METHYL)BENZOIC ACID | 4-([4-(2,6-DIMETHYLMORPHOLIN-4-YL)-6-HYDROXY-1-METHYL-2-OXO-1,2-DIHYDROPYRIMIDIN-5-YL]METHYL)BENZOIC ACID | C19H23N3O5
| | |
13 | 892625-38-6 | (5Z)-5-[(E)-3-[4-(dimethylamino)phenyl]-1-hydroxyprop-2-enylidene]-1-(3-methoxypropyl)-1,3-diazinane-2,4,6-trione | (5Z)-5-[(E)-3-[4-(dimethylamino)phenyl]-1-hydroxyprop-2-enylidene]-1-(3-methoxypropyl)-1,3-diazinane-2,4,6-trione | C19H23N3O5
| | |
14 | 2133816-71-2 | Carbamic acid, N-[2,3-dihydro-2-(1-methyl-2,6-dioxo-3-piperidinyl)-1-oxo-1H-isoindol-4-yl]-, 1,1-dimethylethyl ester | Carbamic acid, N-[2,3-dihydro-2-(1-methyl-2,6-dioxo-3-piperidinyl)-1-oxo-1H-isoindol-4-yl]-, 1,1-dimethylethyl ester | C19H23N3O5
| | |
15 | 664970-87-0 | 6-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-1,3-dimethyl-5-(4-methylphenyl)-1H-pyrrolo[3,4-d]pyrimidine-2,4(3H,6H)-dione | 6-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-1,3-dimethyl-5-(4-methylphenyl)-1H-pyrrolo[3,4-d]pyrimidine-2,4(3H,6H)-dione | C19H23N3O5
| | |